Inhibition of retinal neovascularization by siRNA targeting VEGF165

Molecular Vision

Volumn 14, Issue , 2008, Pages 1965-1973

  Xia, Xiao Bo ^a   Xiong, Si Qi ^a   Song, Wei Tao ^a   Luo, Jei ^a   Wang, Yu Ke ^a   Zhou, Rong Rong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; ISOPROTEIN; OXYGEN; SMALL INTERFERING RNA; VASCULOTROPIN 165;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILENCER GENE; SYSTEM ANALYSIS; WESTERN BLOTTING;

ANGIOGRAPHY; ANIMALS; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MICE; RETINA; RETINAL NEOVASCULARIZATION; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55349085426     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995; 72:638-45.
2. Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 2000; 6:1047-52.
3. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR. MARINA Study GroupSubgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007; 114:246-52.
4. Elbashir SM, Lendeckel W, Tuschl T. RNAinterference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15:188-200.
5. Check E. Firm sets sights on gene silencing to protect vision. Nature 2004; 430:819.
6. Zachary I. Vascular endothelial growth factor. Int J Biochem Cell Biol 1998; 30:1169-74.
7. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura Y, Hida T, Oguchi Y, Ambati J, Miller JW, Gragoudas ES, Ng YS, D'Amore PA, Shima DT, Adamis AP. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 2003; 198:483-9.
8. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994; 35:101-11.
9. Miller JW, Adamis AP, Aiello LP. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 1997; 13:37-50.
10. Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997; 22:251-6.
11. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285:245-8.
12. Ng YS, Krilleke D, Shima DT. VEGF function in vascular pathogenesis. Exp Cell Res 2006; 312:527-37.
13. Guan H, Zhou Z, Wang H, Jia SF, Liu W, Kleinerman ES. A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Inhibits Ewing's Sarcoma Growth in a Xenograft Mouse Model. Clin Cancer Res 2005; 11:2662-9.
14. Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, Yamada H, Hackett SF, Okamoto N, Zack DJ, Semenza GL, Campochiaro PA. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 1999; 40:182-9.
15. Masuda I, Matsuo T, Yasuda T, Matsuo N. Gene transfer with the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 1996; 37:1914-20.
16. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger:short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003; 4:457-67.